Form 4: OHI CEO's Equity Vesting: 123,081 Units Converted

Omega Healthcare Investors CEO C. Taylor Pickett converted 123,081 Profits Interest Units into Operating Partnership Units on September 30, 2025.

Summary

• C. Taylor Pickett, Chief Executive Officer and Director of Omega Healthcare Investors Inc. (OHI), reported changes in his beneficial ownership of derivative securities.
• On September 30, 2025, 60,459 Profits Interest Units (PIUs) vested into Operating Partnership Units (OP Units). This vesting was based on the Absolute Total Shareholder Return for the 2022-2024 performance period.
• Concurrently, an additional 62,622 PIUs vested into OP Units, based on the Relative Total Shareholder Return for the same 2022-2024 performance period.
• In total, 123,081 PIUs converted into OP Units on this date.
• Each OP Unit is redeemable for cash equivalent to the fair market value of one share of OHI common stock, or, at the Issuer's discretion, one share of OHI common stock.
• Following these transactions, Pickett's direct beneficial ownership of Profits Interest Units is 325,884, and his direct beneficial ownership of Operating Partnership Units is 1,134,750.

Sentiment

Score: 7

Explanation: The vesting of a significant number of performance-based equity units for the CEO is a positive indicator of achieved performance targets and continued alignment of management interests with shareholders. It's a routine, positive event for the executive and reflects positively on the company's compensation structure and potentially its past performance.

Positives

• CEO C. Taylor Pickett's equity compensation has vested, converting 123,081 Profits Interest Units into Operating Partnership Units.
• The vesting is tied to performance metrics (Absolute and Relative Total Shareholder Return) over the 2022-2024 period, indicating successful achievement of performance targets.
• Increased direct beneficial ownership of OP Units, which are convertible into OHI common stock, aligns management's interests with shareholders.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of executive equity compensation vesting, common across all industries, particularly for publicly traded companies. It reflects the execution of pre-established long-term incentive plans designed to align executive interests with shareholder value creation. The specific performance periods (2022-2024) and metrics (Absolute and Relative Total Shareholder Return) are standard for such plans in the REIT sector, where Omega Healthcare Investors operates.

Comparison to Industry Standards

• The vesting of performance-based equity awards for a CEO is a standard practice in the REIT industry and broader corporate landscape.
• The use of Total Shareholder Return (TSR) as a performance metric, both absolute and relative, is a common and well-regarded approach for executive compensation, aligning incentives with shareholder returns.
• Companies like Ventas (VTR), Welltower (WELL), and Healthpeak Properties (PEAK), which are peers in the healthcare REIT sector, also utilize similar performance-based equity compensation structures for their executives to drive long-term value.

Corporate Governance

Stakeholder Impact

• **Shareholders:** Increased alignment of CEO's interests with shareholder value through increased equity ownership.
• **Employees:** Demonstrates the company's commitment to performance-based compensation for its leadership.
• **Management:** C. Taylor Pickett's compensation package is enhanced through the vesting of these units.

Key Dates

Keywords

Omega Healthcare Investors, OHI, C. Taylor Pickett, Form 4, Insider Transaction, Equity Compensation, Profits Interest Units, OP Units, Vesting, CEO, Director